Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND: Cardiac allograft vasculopathy (CAV) is a complication beyond the first-year post-heart transplantation (HTx). We aimed to test the utility of cardiac magnetic resonance (CMR) to detect functional/structural changes in HTx recipients with CAV. METHODS: Seventy-seven prospectively recruited HTx recipients beyond the first-year post-HTx and 18 healthy controls underwent CMR, including cine imaging of ventricular function and T1- and T2-mapping to assess myocardial tissue changes. Data analysis included quantification of global cardiac function and regional T2, T1 and extracellular volume based on the 16-segment model. International Society for Heart and Lung Transplantation criteria was used to adjudicate CAV grade (0–3) based on coronary angiography. RESULTS: The majority of HTx recipients (73%) presented with CAV (1: n = 42, 2/3: n = 14, 0: n = 21). Global and segmental T2 (49.5 ± 3.4 ms vs 50.6 ± 3.4 ms, p < 0.001;16/16 segments) were significantly elevated in CAV-0 compared to controls. When comparing CAV-2/3 to CAV-1, global and segmental T2 were significantly increased (53.6 ± 3.2 ms vs. 50.6 ± 2.9 ms, p < 0.001; 16/16 segments) and left ventricular ejection fraction was significantly decreased (54 ± 9% vs. 59 ± 9%, p < 0.05). No global, structural, or functional differences were seen between CAV-0 and CAV-1. CONCLUSIONS: Transplanted hearts display functional and structural alteration compared to native hearts, even in those without evidence of macrovasculopathy (CAV-0). In addition, CMR tissue parameters were sensitive to changes in CAV-1 vs. 2/3 (mild vs. moderate/severe). Further studies are warranted to evaluate the diagnostic value of CMR for the detection and classification of CAV.
Abstract
BACKGROUND: Cardiac allograft vasculopathy (CAV) is a complication beyond the first-year post-heart transplantation (HTx). We aimed to test the utility of cardiac magnetic resonance (CMR) to detect functional/structural changes in HTx recipients with CAV. METHODS: Seventy-seven prospectively recruited HTx recipients beyond the first-year post-HTx and 18 healthy controls underwent CMR, including cine imaging of ventricular function and T1- and T2-mapping to assess myocardial tissue changes. Data analysis included quantification of global cardiac function and regional T2, T1 and extracellular volume based on the 16-segment model. International Society for Heart and Lung Transplantation criteria was used to adjudicate CAV grade (0–3) based on coronary angiography. RESULTS: The majority of HTx recipients (73%) presented with CAV (1: n = 42, 2/3: n = 14, 0: n = 21). Global and segmental T2 (49.5 ± 3.4 ms vs 50.6 ± 3.4 ms, p < 0.001;16/16 segments) were significantly elevated in CAV-0 compared to controls. When comparing CAV-2/3 to CAV-1, global and segmental T2 were significantly increased (53.6 ± 3.2 ms vs. 50.6 ± 2.9 ms, p < 0.001; 16/16 segments) and left ventricular ejection fraction was significantly decreased (54 ± 9% vs. 59 ± 9%, p < 0.05). No global, structural, or functional differences were seen between CAV-0 and CAV-1. CONCLUSIONS: Transplanted hearts display functional and structural alteration compared to native hearts, even in those without evidence of macrovasculopathy (CAV-0). In addition, CMR tissue parameters were sensitive to changes in CAV-1 vs. 2/3 (mild vs. moderate/severe). Further studies are warranted to evaluate the diagnostic value of CMR for the detection and classification of CAV.
참고문헌 (49)
- Lee MS, "Cardiac allograft vasculopathy : a review", Catheter Cardiovasc Interv, 92, pp.E527~E536 (2018)
- Lund LH, "The registry of the International Society for Heart and Lung Transplantation : Thirty-fourth Adult Heart Transplantation Report-2017; Focus theme : allograft ischemic time", J Heart Lung Transplant, 36, pp.1037~1046 (2017)
- Yusen RD, "The registry of the International Society for Heart and Lung Transplantation : Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus theme : primary diagnostic indications for transplant", J Heart Lung Transplant, 35, pp.1170~1184 (2016)
- Lee F, "Cardiac allograft vasculopathy : insights on pathogenesis and therapy", Clin Transplant, 34, pp.e13794~ (2020)
- Lu WH, "Diverse morphologic manifestations of cardiac allograft vasculopathy : a pathologic study of 64 allograft hearts", J Heart Lung Transplant, 30, pp.1044~1050 (2011)
- Abu-Qaoud MS, "Lack of relationship between microvascular and macrovascular disease in heart transplant recipients", Transplantation, 94, pp.965~970 (2012)
- Kübrich M, "Impact of coronary endothelial dysfunction on adverse longterm outcome after heart transplantation", Transplantation, 85, pp.1580~1587 (2008)
- Awad M, "Early denervation and later reinnervation of the heart following cardiac transplantation : a review", J Am Heart Assoc, 5, pp.e004070~ (2016)
- Gao SZ, "Progressive coronary luminal narrowing after cardiac transplantation", Circulation, 82, pp.IV269~IV275 (1990)
- Sharples LD, "Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy", Transplantation, 76, pp.679~682 (2003)
- St Goar FG, "Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound", Circulation, 86, pp.756~763 (1992)
- Pollack A, "Detection and imaging of cardiac allograft vasculopathy", JACC Cardiovasc Imaging, 6, pp.613~623 (2013)
- Ricci MA, "Vascular complications of cardiac catheterization", Am J Surg, 167, pp.375~378 (1994)
- Tadic M, "Multimodality evaluation of the right ventricle : an updated review", Clin Cardiol, 38, pp.770~776 (2015)
- Ferreira VM, "Myocardial tissue characterization by magnetic resonance imaging : novel applications of T1 and T2 mapping", J Thorac Imaging, 29, pp.147~154 (2014)
- Puntmann VO, "Society for Cardiovascular Magnetic Resonance(SCMR)expert consensus for CMR imaging endpoints in clinical research : part I-analytical validation and clinical qualification", J Cardiovasc Magn Reson, 20, pp.67~ (2018)
- Moon JC, "Myocardial T1 mapping and extracellular volume quantification : a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement", J Cardiovasc Magn Reson, 15, pp.92~ (2013)
- Giri S, "T2 quantification for improved detection of myocardial edema", J Cardiovasc Magn Reson, 11, pp.56~ (2009)
- Messroghli DR, "Modified Look-Locker inversion recovery(MOLLI)for high-resolution T1 mapping of the heart", Magn Reson Med, 52, pp.141~146 (2004)
- Haaf P, "Cardiac T1 mapping and extracellular volume(ECV)in clinical practice : a comprehensive review", J Cardiovasc Magn Reson, 18, pp.89~ (2017)
- Cerqueira MD, "Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association", Circulation, 105, pp.539~542 (2002)
- Dolan RS, "Cardiac structure-function MRI in patients after heart transplantation", J Magn Reson Imaging, 49, pp.678~687 (2019)
- Dolan RS, "Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation", JACC Cardiovasc Imaging, 12, pp.1632~1641 (2019)
- Mehra MR, "International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010", J Heart Lung Transplant, 29, pp.717~727 (2010)
- Markl M, "Myocardial T2-mapping and velocity mapping : changes in regional left ventricular structure and function after heart transplantation", Magn Reson Med, 70, pp.517~526 (2013)
- Yuan Y, "CMR-derived extracellular volume fraction(ECV)in asymptomatic heart transplant recipients : correlations with clinical features and myocardial edema", Int J Cardiovasc Imaging, 34, pp.1959~1967 (2018)
- Miller CA, "Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy", J Am Coll Cardiol, 63, pp.799~808 (2014)
- Chih S, "Perfusion cardiac magnetic resonance imaging as a rule-out test for cardiac allograft vasculopathy", Am J Transplant, 16, pp.3007~3015 (2016)
- Erbel C, "Myocardial perfusion reserve and strain-encoded CMR for evaluation of cardiac allograft microvasculopathy", JACC Cardiovasc Imaging, 9, pp.255~266 (2016)
- Korosoglou G, "Strain-encoded cardiac magnetic resonance for the evaluation of chronic allograft vasculopathy in transplant recipients", Am J Transplant, 9, pp.2587~2596 (2009)
- Korosoglou G, "Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy", Am Heart J, 159, pp.643~651 (2010)
- Braggion-Santos MF, "Late gadolinium enhancement assessed by cardiac magnetic resonance imaging in heart transplant recipients with different stages of cardiac allograft vasculopathy", Eur Heart J Cardiovasc Imaging, 15, pp.1125~1132 (2014)
- van Heeswijk RB, "Quantification of myocardial interstitial fibrosis and extracellular volume for the detection of cardiac allograft vasculopathy", Int J Cardiovasc Imaging, 36, pp.533~542 (2020)
- Ajluni SC Jr, "Non-invasive imaging in the evaluation of cardiac allograft vasculopathy in heart transplantation : a systematic review", Curr Probl Cardiol (2022)
- Sciaccaluga C, "The role of non-invasive imaging modalities in cardiac allograft vasculopathy : an updated focus on current evidences", Heart Fail Rev (2021)[DOI]
- Costanzo MR, "The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients", J Heart Lung Transplant, 29, pp.914~956 (2010)
- Elkaryoni A, "Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients : a systematic review and meta-analysis study", Echocardiography, 36, pp.528~536 (2019)
- Clerkin KJ, "New developments for the detection and treatment of cardiac vasculopathy", Curr Opin Cardiol, 32, pp.316~325 (2017)
- Clerkin KJ, "Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy", J Heart Lung Transplant, 35, pp.1040~1041 (2016)
- Akosah KO, "Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography", J Heart Lung Transplant, 13, pp.1024~1038 (1994)
- Masarone D, "The role of echocardiography in the management of heart transplant recipients", Diagnostics(Basel), 11, pp.2338~ (2021)
- Clemmensen TS, "Left ventricular global longitudinal strain predicts major adverse cardiac events and all-cause mortality in heart transplant patients", J Heart Lung Transplant, 36, pp.567~576 (2017)
- Pober JS, "Cardiac allograft vasculopathy : current review and future research directions", Cardiovasc Res, 117, pp.2624~2638 (2021)
- Schepis T, "Comparison of dual source computed tomography versus intravascular ultrasound for evaluation of coronary arteries at least one year after cardiac transplantation", Am J Cardiol, 104, pp.1351~1356 (2009)
- Shah NR, "Coronary CTA for surveillance of cardiac allograft vasculopathy", Curr Cardiovasc Imaging Rep, 12, pp.1~7 (2019)
- Oebel S, "Comprehensive morphologic and functional imaging of heart transplant patients : first experience with dynamic perfusion CT", Eur Radiol, 28, pp.4111~4121 (2018)
- Günther A, "The predictive value of coronary artery calcium detected by computed tomography in a prospective study on cardiac allograft vasculopathy in heart transplant patients", Transpl Int, 31, pp.82~91 (2018)
- Zerhouni EA, "Human heart : tagging with MR imaging--a method for noninvasive assessment of myocardial motion", Radiology, 169, pp.59~63 (1988)
- Aletras AH, "DENSE : displacement encoding with stimulated echoes in cardiac functional MRI", J Magn Reson, 137, pp.247~252 (1999)